New Marker of Platelet Activation, SCUBE1, Is Elevated in Hypertensive Patients

By Ozkan Gulsum  

American Journal of Hypertension, Vol. 26, Iss. 6, 2013-06 ,pp. : 748-753

Oxford University Press

Access to resources Recommend Favorite

Flow cytometric analysis of platelet activation in hypertensive patients. Effect of doxazosin

By Labios M.   Martinez M.   Gabriel F.   Gomez-Biedma S.   Guiral V.   Vivo M.   Aznar J.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite

In vivo effect of losartan on platelet aggregation in patients with hypertension

By Akdemir Ramazan   Özhan Hakan   Yazici Mehmet   Gunduz Huseyin   Duran Sadık   Gurel Cigdem   Ozdas Sule   Uyan Cihangir   Basar Isık   Ulutin Turgut  

Heart and Vessels, Vol. 19, Iss. 4, 2004-07 ,pp. : 167-171

Springer Publishing Company

Access to resources Recommend Favorite

Simvastatin prevents ERK activation in myocardial hypertrophy of spontaneously hypertensive rats

By Huang Chaoyang   Liu Zhong   Wang Zhankun   Shen Zhe   Zhu Jianhua  

Scandinavian Cardiovascular Journal, Vol. 44, Iss. 6, 2010-12 ,pp. : 346-351

Informa Healthcare

Access to resources Recommend Favorite

Which is a Better Treatment for Hypertensive Patients with Diabetes: A Combination of Losartan and Hydrochlorothiazide or a Maximum Dose of Losartan?

By Nishimura Haruo   Shintani Mitsuyo   Maeda Koji   Otoshi Kentaro   Fukuda Masahiro   Okuda Joji   Nishi Shigeo   Ohashi Shinichiro   Kato Sumiko   Baba Yasuto  

Clinical and Experimental Hypertension, Vol. 35, Iss. 8, 2013-12 ,pp. : 582-588

Informa Healthcare

Access to resources Recommend Favorite